• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Politan Nominates Two Candidates for Masimo Board

    5/2/23 7:00:00 AM ET
    $BG
    $CAH
    $CNC
    $LOW
    Packaged Foods
    Consumer Staples
    Other Pharmaceuticals
    Health Care
    Get the next $BG alert in real time by email

    Nominees Michelle Brennan and Quentin Koffey Bring Relevant Industry Experience, a Focus on Profitable Growth and Shareholder Alignment to a Board in Need of Independent Oversight

    Visit www.AdvanceMasimo.com for Additional Information

    Politan Capital Management (together with its affiliates, "Politan"), a 9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today announced that it has nominated two candidates for election to the Masimo Board of Directors (the "Board") at the upcoming 2023 Annual Meeting of Stockholders (the "Annual Meeting"), which is currently scheduled for June 26, 2023.

    Politan's nominees are:

    • Michelle Brennan, a former senior executive at Johnson & Johnson ("J&J") for more than 30 years, where she oversaw medical device businesses globally as well as consumer pharmaceutical businesses. At J&J, Michelle successfully scaled multiple businesses from inception to several billion in revenue and led efforts to invest in innovation that resulted in successful new product launches. Michelle is currently an independent director at Cardinal Health (NYSE:CAH) and recently served on the Board of Coupa Software (NASDAQ:COUP). If elected to the Masimo Board, Michelle would bring decades of successful experience reinvigorating profitable growth in the healthcare sector.



    • Quentin Koffey, Managing Partner and Chief Investment Officer of Politan. Quentin has an established track record of working constructively with boards and management teams to enhance shareholder value, including at companies such as Centene (NYSE:CNC), Lowe's Companies (NYSE:LOW), Louisiana-Pacific (NYSE:LPX), Bunge (NYSE:BG), and Marathon Petroleum (NYSE:MPC). If elected to the Masimo Board, Quentin would bring a shareholder perspective as one of the Company's largest owners, in addition to highly relevant corporate governance, capital allocation and finance experience.

    Mr. Koffey stated:

    "As a 9% owner of Masimo, Politan is fully aligned with the success of the Company and its ability to generate long-term value. We believe independent oversight is needed on the Board in order to fix the lack of confidence in Masimo's governance that has led to a persistent valuation discount of over $4 billion. This is why Politan has nominated two ideally qualified director candidates for election at the 2023 Annual Meeting who are committed to representing the interests of all shareholders.

    Over the past eight months, we have attempted to engage constructively with Masimo's Board – but they have refused to even meet with us. Despite our track record of working privately with companies to fix strategic, operational and governance matters, Masimo's Board has taken an extraordinarily aggressive and hostile approach to our engagement. The Board has enacted widely criticized and illegal bylaws, attempted to use litigation to force Politan to disclose commercially sensitive information and tried to contact and pressure Politan's own investors. These actions are consistent with Masimo's history of disregard for shareholders and further evidence of the need for change. Following the Company's March 23rd announcement that it would adopt some long overdue governance changes, we again attempted to work constructively with the Company, only to find the same utter lack of interest in engagement.

    Together, Michelle and I would bring a unique set of needed skills to the Masimo Board. She has deep expertise from decades spent in relevant roles at one of the most respected healthcare and consumer products companies in the world, in addition to experience as a public company director. I would add a true independent ownership perspective and my experience from dozens of collaborative engagements focused on improving capital allocation and corporate governance at companies across sectors. We both believe in the future of Masimo and that it has the opportunity for tremendous ongoing success. By electing us, shareholders will be adding to the Board independent, objective directors with the right skills and experience to help the Company maximize its potential for all its stakeholders.

    We look forward to engaging with our fellow shareholders in the near future."

    For additional information, shareholders can visit www.AdvanceMasimo.com.

    Full Biographies of Politan's Nominees

    Michelle Brennan is an accomplished healthcare executive with over 30 years of experience at Johnson & Johnson. Michelle most recently served as Global Value Creation Leader and a member of the Medical Device Executive Leadership Team. Prior to this, she held a variety of roles, including Company Group Chair of J&J's Medical Device business in Europe, Middle East & Africa. Over her tenure, Michelle had P&L responsibility for a more than $5 billion medical device business operating across diverse business models and geographies. She also successfully scaled multiple businesses from inception to several billion in revenue and led efforts to invest in innovation as well as optimize the R&D process, which resulted in more effective and profitable product launches and more efficient spend. Michelle has broad operational experience across medical devices and consumer pharmaceuticals and is known for her expertise in strategy implementation, new product innovation, and business transformation.

    Michelle is currently an independent director at Cardinal Health (NYSE:CAH) and is a member of the Audit and Human Resources & Compensation Committees. She recently served on the Board of Coupa Software (NASDAQ:COUP) as an independent director, where she was Chair of the Nominating and Corporate Governance Committee and a member of the Audit Committee, until the completion of Coupa's acquisition by Thoma Bravo for $8 billion in February of 2023. Michelle holds a BA from the University of Kansas and has attended Executive MBA courses at the Wharton School of the University of Pennsylvania.

    Quentin Koffey is the Managing Partner and Chief Investment Officer of Politan Capital, a top shareholder of Masimo Corporation. In this role, Quentin leads efforts to work actively with management teams, boards of directors, and shareholders of portfolio companies on strategic, operational, and corporate governance matters to unlock long-term value for shareholders. Prior to founding Politan, Quentin was a partner at Senator Investment Group LP, where he created and led its shareholder engagement efforts, and a Portfolio Manager for Strategic Investments at The D.E. Shaw Group, where he started and led the firm's shareholder engagement strategy. Quentin also served as a Portfolio Manager at Elliott Management Corporation where he focused on active investments in public and private equity and credit.

    Over his career, Quentin has established a track record of working constructively with boards and management teams to enhance shareholder value, including at companies such as Centene (NYSE:CNC), Lowe's Companies (NYSE:LOW), Louisiana-Pacific (NYSE:LPX), Bunge (NYSE:BG), and Marathon Petroleum (NYSE:MPC). Quentin holds a BA from Yale College, a JD from Stanford Law School, and an MBA from Stanford Graduate School of Business.

    Cautionary Statement Regarding Forward-Looking Statements

    This press release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein in any state to any person. The information herein contains "forward-looking statements." Specific forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and include, without limitation, words such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "potential," "targets," "forecasts," "seeks," "could," "should" or the negative of such terms or other variations on such terms or comparable terminology. Similarly, statements that describe our objectives, plans or goals are forward-looking. Forward-looking statements are subject to various risks and uncertainties and assumptions. There can be no assurance that any idea or assumption herein is, or will be proven, correct. If one or more of the risks or uncertainties materialize, or if Politan's underlying assumptions prove to be incorrect, the actual results may vary materially from outcomes indicated by these statements. Accordingly, forward-looking statements should not be regarded as a representation by Politan that the future plans, estimates or expectations contemplated will ever be achieved.

    Certain Information Concerning the Participants

    Politan Capital Management LP ("Politan Capital") and the other Participants (as defined below) will file a preliminary proxy statement and accompanying BLUE universal proxy card with the Securities and Exchange Commission (the "SEC") on May 2, 2023 to be used to solicit proxies for, among other matters, the election of its slate of director nominees at the Annual Meeting. Promptly after filing its definitive proxy statement with the SEC, Politan Capital will mail the definitive proxy statement and accompanying BLUE universal proxy card to each stockholder entitled to vote at the 2023 Annual Meeting.

    The participants in the proxy solicitation are Politan Capital, Politan Capital Management GP LLC, Politan Capital Partners GP LLC, Politan Capital NY LLC, Politan Intermediate Ltd., Politan Capital Partners Master Fund LP ("Politan Master Fund"), Politan Capital Partners LP ("Politan LP"), Politan Capital Offshore Partners LP ("Politan Offshore" and collectively with Politan Master Fund and Politan LP, the "Politan Funds"), Quentin Koffey, Matthew Hall, Aaron Kapito and Michelle Brennan (collectively, the "Participants").

    As of the date hereof, (i) Politan Master Fund directly owns 4,712,518 shares of common stock, par value $0.001 per share, of Masimo (the "Common Stock"), and (ii) Politan Capital NY LLC is the direct and record owner of 1,000 shares of Common Stock.

    Politan Capital, as the investment adviser to the Politan Funds, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) 4,713,518 shares of Common Stock (the "Politan Shares") and, therefore, Politan Capital may be deemed to be the beneficial owner of all of the Politan Shares. The Politan Shares collectively represent approximately 9.0% of the outstanding shares of Common Stock based on 52,601,943 shares of Common Stock outstanding as of January 28, 2023, as reported in Masimo's Annual Report on Form 10-K filed on March 1, 2023. As the general partner of Politan Capital, Politan Capital Management GP LLC may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all of the Politan Shares and, therefore, Politan Capital Management GP LLC may be deemed to be the beneficial owner of all of the Politan Shares. As the general partner of the Politan Funds, Politan Capital Partners GP LLC may be deemed to have the shared power to vote or to direct the vote of (and the shared power to dispose or direct the disposition of) all of the Politan Shares and, therefore, Politan Capital Partners GP LLC may be deemed to be the beneficial owner of all of the Politan Shares. By virtue of Mr. Koffey's position as the managing partner and chief investment officer of Politan and as the managing member of Politan Capital Management GP LLC and Politan Capital Partners GP LLC, Mr. Koffey may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all of the Politan Shares and, therefore, Mr. Koffey may be deemed to be the beneficial owner of all of the Politan Shares. As of the date hereof, none of Mr. Hall, Mr. Kapito or Ms. Brennan own beneficially or of record any shares of Common Stock.

    Important Information and Where to Find It

    POLITAN CAPITAL STRONGLY ADVISES ALL STOCKHOLDERS OF MASIMO TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEBSITE AT WWW.SEC.GOV. THE DEFINITIVE PROXY STATEMENT, WHEN FILED, AND OTHER RELEVANT DOCUMENTS, WILL ALSO BE AVAILABLE ON WWW.ADVANCEMASIMO.COM AND THE SEC WEBSITE, FREE OF CHARGE, OR BY DIRECTING A REQUEST TO THE PARTICIPANTS' PROXY SOLICITOR, D.F. KING & CO., INC., 48 WALL STREET, 22ND FLOOR, NEW YORK, NEW YORK 10005 (STOCKHOLDERS CAN CALL TOLL-FREE: +1 (866) 620-9554).

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230502005565/en/

    Get the next $BG alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BG
    $CAH
    $CNC
    $LOW

    CompanyDatePrice TargetRatingAnalyst
    Centene Corporation
    $CNC
    7/2/2025$45.00Buy → Neutral
    UBS
    Centene Corporation
    $CNC
    7/2/2025$48.00Overweight → Neutral
    Analyst
    Marathon Petroleum Corporation
    $MPC
    6/18/2025$170.00In-line
    Evercore ISI
    Marathon Petroleum Corporation
    $MPC
    6/10/2025$152.00 → $163.00Buy
    TD Cowen
    Centene Corporation
    $CNC
    6/9/2025$70.00Overweight
    Morgan Stanley
    Cardinal Health Inc.
    $CAH
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    Centene Corporation
    $CNC
    6/2/2025$65.00Overweight → Equal Weight
    Barclays
    Louisiana-Pacific Corporation
    $LPX
    5/7/2025$110.00Hold → Buy
    Loop Capital
    More analyst ratings

    $BG
    $CAH
    $CNC
    $LOW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Bunge and Viterra Complete Merger to Create Premier Global Agribusiness Solutions Company

      Bunge Global SA (NYSE:BG) ("Bunge") today announced the successful closing of its previously announced merger with Viterra Limited ("Viterra"), marking the creation of a premier global agribusiness solutions company for food, feed and fuel. Greg Heckman, Bunge's Chief Executive Officer, said: "Today is a defining moment for our company and our global team as we complete this transformative business combination. I'm grateful to our colleagues whose energy, collaboration and commitment brought us to this milestone. Together, we've formed a stronger organization with enhanced capabilities and expertise to meet the evolving needs of our customers, maximize value for our stakeholders and fulfi

      7/2/25 1:15:00 PM ET
      $BG
      Packaged Foods
      Consumer Staples
    • CENTENE CORPORATION WITHDRAWS 2025 GUIDANCE

      ST. LOUIS, July 1, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (Centene, the Company) is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance, including the underlying guidance elements. Marketplace 2025 Risk Adjustment Update The Company recently received and analyzed its first view of 2025 industry Health Insurance Marketplace (Marketplace) data from Wakely, an independent actuarial firm, covering 22 of Centene's 29 Marketplace states, and representing approximately 72% of the Company's Marketplace membership. This data is submitted to Wakely by most Marketplace insurance carriers. Based upon the Company's preliminary interpretation of the data

      7/1/25 4:40:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Bunge Completes Sale of its North America Corn Milling Business

      Bunge Global SA (NYSE:BG) announced today it has completed the previously announced sale of its North America dry corn and corn masa milling business. About Bunge At Bunge (NYSE:BG), our purpose is to connect farmers to consumers to deliver essential food, feed and fuel to the world. With more than two centuries of experience, unmatched global scale and deeply rooted relationships, we work to strengthen global food security, increase sustainability where we operate, and help communities prosper. As a world leader in oilseed processing and a leading producer and supplier of specialty plant-based oils and fats, we value our partnerships with farmers to bring quality products from where th

      7/1/25 7:00:00 AM ET
      $BG
      Packaged Foods
      Consumer Staples

    $BG
    $CAH
    $CNC
    $LOW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Burdick Kenneth A was granted 556 shares, increasing direct ownership by 0.15% to 367,053 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      7/2/25 4:59:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Deveydt Wayne S was granted 602 shares, increasing direct ownership by 3% to 19,523 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      7/2/25 4:58:48 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Tanji Kenneth was granted 463 shares, increasing direct ownership by 10% to 5,145 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      7/2/25 4:58:36 PM ET
      $CNC
      Medical Specialities
      Health Care

    $BG
    $CAH
    $CNC
    $LOW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Centene downgraded by Analyst with a new price target

      Analyst downgraded Centene from Overweight to Neutral and set a new price target of $48.00

      7/2/25 7:47:37 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene downgraded by UBS with a new price target

      UBS downgraded Centene from Buy to Neutral and set a new price target of $45.00

      7/2/25 7:47:37 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Evercore ISI initiated coverage on Marathon Petroleum with a new price target

      Evercore ISI initiated coverage of Marathon Petroleum with a rating of In-line and set a new price target of $170.00

      6/18/25 7:58:15 AM ET
      $MPC
      Integrated oil Companies
      Energy

    $BG
    $CAH
    $CNC
    $LOW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Commercial Officer Hessling Ricky D. bought $269,440 worth of shares (2,000 units at $134.72), increasing direct ownership by 20% to 12,162 units (SEC Form 4)

      4 - Marathon Petroleum Corp (0001510295) (Issuer)

      3/13/25 6:55:55 AM ET
      $MPC
      Integrated oil Companies
      Energy
    • Director Bayh Evan bought $133,700 worth of shares (1,000 units at $133.70), increasing direct ownership by 1% to 69,305 units (SEC Form 4)

      4 - Marathon Petroleum Corp (0001510295) (Issuer)

      3/7/25 7:10:39 AM ET
      $MPC
      Integrated oil Companies
      Energy
    • Director Simkins Lawrence bought $245,532 worth of shares (1,000 units at $245.53) (SEC Form 4)

      4 - LOWES COMPANIES INC (0000060667) (Issuer)

      12/23/24 4:10:11 PM ET
      $LOW
      RETAIL: Building Materials
      Consumer Discretionary

    $BG
    $CAH
    $CNC
    $LOW
    SEC Filings

    See more
    • SEC Form 144 filed by Marathon Petroleum Corporation

      144 - Marathon Petroleum Corp (0001510295) (Subject)

      7/3/25 11:00:52 AM ET
      $MPC
      Integrated oil Companies
      Energy
    • Bunge Limited filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Bunge Global SA (0001996862) (Filer)

      7/2/25 5:17:45 PM ET
      $BG
      Packaged Foods
      Consumer Staples
    • Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - CENTENE CORP (0001071739) (Filer)

      7/1/25 4:43:52 PM ET
      $CNC
      Medical Specialities
      Health Care

    $BG
    $CAH
    $CNC
    $LOW
    Leadership Updates

    Live Leadership Updates

    See more
    • Shareholders Elect Four Independent Directors to the Six Flags Board

      Six Flags Entertainment Corporation (NYSE:FUN), the largest regional amusement park operator in North America, announced today that its shareholders elected Sandra (Sandy) Cochran, Michael Colglazier, Felipe Dutra, and Steven Hoffman to the Board of Directors of Six Flags Entertainment Corporation for 3-year terms expiring in 2028. Shareholders also confirmed the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm, approved an advisory vote on the compensation of the Company's named executive officers, and confirmed a 1-year frequency for shareholder advisory votes on executive compensation. "I want to welcome Sandy, Michael, Felipe and St

      6/25/25 5:00:00 PM ET
      $BUD
      $CBRL
      $DG
      $FUN
      Beverages (Production/Distribution)
      Consumer Staples
      Restaurants
      Consumer Discretionary
    • LP Building Solutions Names Tony Hamill as Chief Operating Officer

      LP Building Solutions (LP), a leading manufacturer of high-performance building products, today announced the appointment of Tony Hamill as Senior Vice President, Chief Operating Officer, effective June 30, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250619923354/en/LP Building Solutions Chief Operating Officer Tony Hamill "As we execute our long-term growth strategy, I am pleased to appoint Tony to the newly created role of Chief Operating Officer," said LP President Jason Ringblom. "With over 30 years of leadership experience in engineering and manufacturing—much of it within our own organization—Tony brings comprehen

      6/19/25 9:00:00 AM ET
      $LPX
      Forest Products
      Basic Materials
    • After Major Oncology Conference, All Eyes Turn to Industry Innovation

      USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

      6/12/25 9:00:00 AM ET
      $CAH
      $CTOR
      $CTXR
      $ONCY
      Other Pharmaceuticals
      Health Care
      Biotechnology: Pharmaceutical Preparations

    $BG
    $CAH
    $CNC
    $LOW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Centene Corporation

      SC 13G - CENTENE CORP (0001071739) (Subject)

      11/14/24 4:06:01 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Centene Corporation

      SC 13G/A - CENTENE CORP (0001071739) (Subject)

      11/13/24 3:02:23 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Centene Corporation

      SC 13G/A - CENTENE CORP (0001071739) (Subject)

      11/12/24 9:55:15 AM ET
      $CNC
      Medical Specialities
      Health Care

    $BG
    $CAH
    $CNC
    $LOW
    Financials

    Live finance-specific insights

    See more
    • Marathon Petroleum Corp. to Report Second-Quarter Financial Results on August 5, 2025

      FINDLAY, Ohio, June 5, 2025 /PRNewswire/ -- Marathon Petroleum Corp. (NYSE:MPC) will host a conference call on Tuesday, August 5, 2025, at 11 a.m. EDT to discuss 2025 second-quarter financial results. Interested parties may listen to the conference call by visiting MPC's website at www.marathonpetroleum.com. A replay of the webcast will be available on MPC's website for two weeks. Financial information, including the earnings release and other investor-related material, will also be available online prior to the conference call and webcast at www.marathonpetroleum.com. About Marathon Petroleum Corporation MPC is a leading, integrated, downstream and midstream energy company headquartered in

      6/5/25 5:25:00 PM ET
      $MPC
      Integrated oil Companies
      Energy
    • LOWE'S COMPANIES, INC. ANNOUNCES INCREASE IN QUARTERLY CASH DIVIDEND TO $1.20 PER SHARE

      MOORESVILLE, N.C., May 30, 2025 /PRNewswire/ -- The board of directors of Lowe's Companies, Inc. (NYSE:LOW) has declared a quarterly cash dividend of one dollar and 20 cents ($1.20) per share, payable Aug. 6, 2025, to shareholders of record as of July 23, 2025.  This represents a 4% increase over the company's previous dividend of one dollar and 15 cents ($1.15) per share. "We are pleased with the ongoing transformation of the company, despite near-term challenges in the macro environment.  We're evolving our Total Home strategy so that we will be well-positioned to capitalize

      5/30/25 8:52:00 AM ET
      $LOW
      RETAIL: Building Materials
      Consumer Discretionary
    • LOWE'S REPORTS FIRST QUARTER 2025 SALES AND EARNINGS RESULTS

      — Comparable Sales Decreased 1.7%; Diluted EPS of $2.92 —— Affirms Full Year 2025 Outlook — MOORESVILLE, N.C., May 21, 2025 /PRNewswire/ -- Lowe's Companies, Inc. (NYSE:LOW) today reported net earnings of $1.6 billion and diluted earnings per share (EPS) of $2.92 for the quarter ended May 2, 2025, compared to diluted EPS of $3.06 in the first quarter of 2024. Total sales for the quarter were $20.9 billion, compared to $21.4 billion in the prior-year quarter. Comparable sales for the quarter decreased 1.7% as unfavorable weather earlier in the quarter was partially offset by mi

      5/21/25 6:00:00 AM ET
      $LOW
      RETAIL: Building Materials
      Consumer Discretionary